← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Countervail Corporation
Charlotte, NC
$3,028,489
Total funding
2
Grants
Funding over time
peak $981.7K · FY2010–18$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$3,028,489 · 2
By mechanism
R44$2,803,264 · 1
R43$225,225 · 1
Investigators at Countervail Corporation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Definitive Studies For Use Of Galantamine As A Pre-Treatment Countermeasure Again$981,654
R44 · FY2011 · NS
Definitive Studies For Use Of Galantamine As A Pre-Treatment Countermeasure Again$844,970
R44 · FY2014 · NS
Definitive Studies For Use Of Galantamine As A Pre-Treatment Countermeasure Again$630,123
R44 · FY2015 · NS
Definitive Studies For Use Of Galantamine As A Pre-Treatment Countermeasure Again$346,517
R44 · FY2010 · NS
Rapid Baseline Free Organophosphate Exposure Diagnostic Test$225,225
R43 · FY2018 · NS